Dark

Check out our Level2View

APOP
Cellect Biotechnology Ltd.
stock NASDAQ

Inactive

Oct 28, 2021

13.17USD+0.381%(+0.05)17,433

Pre-market

0.00USD-100.000%(-13.12)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Oct 15, 2021

04:01PM EDT Cellect Biotechnology Announces Record Date and Distribution Date GlobeNewswire Inc

Sep 27, 2021

02:30PM EDT Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher Benzinga

01:01PM EDT Why Cellect Biotechnology Shares Are Rising Today Benzinga

12:34PM EDT Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide Benzinga

10:15AM EDT Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August Benzinga

09:11AM EDT Cellect Biotech Reports Shareholder Approval Of Deal With Quoin Pharma Benzinga

09:10AM EDT Cellect Biotechnology Announces Shareholder Approval of Strategic GlobeNewswire Inc

Sep 24, 2021

08:34AM EDT Cellect Biotech Shares Being Effected By 1-For-4 Reverse Stock Split Friday Morning Benzinga

Sep 3, 2021

03:26PM EDT Mid-Afternoon Market Update: Crude Oil Down 1%; MongoDB Shares Jump After Q2 Results Benzinga

12:03PM EDT Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge Benzinga

10:10AM EDT Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August Benzinga

09:01AM EDT Benzinga Pro's Top 5 Stocks To Watch For Friday, Sept. 3, 2021: LULU, ROKU, ANY, APOP, IPHA Benzinga

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

06:41AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.30 A.M. EDT). RTTNews

Sep 2, 2021

04:20PM EDT Cellect Biotechnology Announces the ApoGraft Bone Marrow Transplantation of First Patient in U.S. Benzinga

04:20PM EDT Cellect Biotechnology Announces the ApoGraft GlobeNewswire Inc

Aug 31, 2021

06:15AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 6.00 A.M. EDT). RTTNews

Aug 24, 2021

04:17PM EDT Cellect Biotechnology Q2 EPS $(0.004) Up From $(0.007) YoY Benzinga

04:16PM EDT Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter GlobeNewswire Inc

Aug 16, 2021

05:47AM EDT Cellect Biotechnology Shares Rise 17% Premarket; Co Announced Friday SEC Declared Co's Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals Benzinga

Aug 13, 2021

04:20PM EDT Special General Meeting of Shareholders Scheduled for September 19, 2021 GlobeNewswire Inc

Jun 17, 2021

02:33PM EDT Mid-Afternoon Market Update: Nasdaq Gains Over 100 Points; CureVac Shares Plummet Benzinga

12:09PM EDT Mid-Day Market Update: Gold Drops Over 4%; Midatech Pharma Shares Jump Benzinga

10:13AM EDT Mid-Morning Market Update: Markets Mixed; Kroger Earnings Top Views Benzinga

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

05:57AM EDT Cellect Biotechnology Shares Trading Up 40% Premarket; Co Announced Wednesday, Filed a Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals Benzinga

Jun 16, 2021

06:58PM EDT Cellect Biotechnology Files Registration Statement in Connection GlobeNewswire Inc

Apr 19, 2021

12:10PM EDT Cellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD Study Benzinga

08:10AM EDT Cellect Biotechnology Reports Data from Phase 1/2 Clinical Trial Met The Primary Objective Benzinga

08:00AM EDT Cellect Biotechnology Reports Top Line Data from Phase 1/2 GlobeNewswire Inc

Mar 29, 2021

09:29AM EDT Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today reported financial and operating results for the fourth quarter and full year ended December 31, 2020 and provided a corporate update. GlobeNewswire Inc

Mar 26, 2021

10:38AM EDT Mid-Morning Market Update: Markets Open Higher; Madison Square Garden To Acquire MSG Networks Benzinga

07:28AM EDT The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs Benzinga

Mar 25, 2021

02:39PM EDT Mid-Afternoon Market Update: Dow Rises 75 Points; Rite Aid Shares Plummet Benzinga

12:08PM EDT Mid-Day Market Update: Crude Oil Down Over 4%; Cellect Biotechnology Shares Surge Benzinga

10:12AM EDT Mid-Morning Market Update: Markets Mostly Lower; Darden Restaurants Tops Q3 Views Benzinga

09:54AM EDT Cellect Biotechnology and Quoin Pharmaceuticals Yesterday Announced Strategic Merger; Cellect Shareholders To Retain 25% Of The Combined Company Pre-funding Benzinga

07:58AM EDT The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut Benzinga

Mar 24, 2021

05:26PM EDT Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger GlobeNewswire Inc

Nov 20, 2020

08:07AM EST Cellect Biotechnology Q3 EPS $(0.01) Up From $(0.12) YoY Benzinga

08:00AM EST Promising Progress on Clinical DevelopmentProgress, Collaborations and Partnering GlobeNewswire Inc

Oct 29, 2020

08:30AM EDT Cellect Biotechnology Commences Collaboration With XNK Therapeutics To Advance Novel NK Cell-Based Therapies; Adds Another Partner For Its Functional Cell Selection Technology Benzinga

08:00AM EDT Adding to a growing roster of partners, Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced that it has entered into and commenced a collaborative development program with Sweden-based XNK Therapeutics, a pioneer in natural killer (NK) cell-based therapies. GlobeNewswire Inc

Oct 22, 2020

08:03AM EDT Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraft Benzinga

Sep 21, 2020

08:30AM EDT Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations GlobeNewswire Inc

Aug 12, 2020

08:10AM EDT Cellect Biotechnology Q2 Net Loss $2.54 Mln Or $0.007/Shr Vs $0.24 Mln Or $0.001/Shr Last Year RTTNews

08:01AM EDT Cellect Biotechnology Reports Second Quarter Financial and Operating Results; PR Newswire

Aug 6, 2020

11:34AM EDT Cellect Biotech Earlier Reported European Patent Office Granted Co. Pivotal Patent For Stem Cells Activiation Benzinga

08:32AM EDT Cellect Biotechnology Says European Patent Office Grants Pivotal Patent For Stem Cells Activation RTTNews

08:31AM EDT European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem PR Newswire

Share